Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.

Rebetz J, Tian D, Persson A, Widegren B, Salford LG, Englund E, Gisselsson D, Fan X.

PLoS One. 2008 Apr 9;3(4):e1936. doi: 10.1371/journal.pone.0001936.

2.

What is the clinical value of cancer stem cell markers in gliomas?

Dahlrot RH, Hermansen SK, Hansen S, Kristensen BW.

Int J Clin Exp Pathol. 2013;6(3):334-48. Epub 2013 Feb 15. Review.

3.

[Glial stem cells and their relationship with tumour angiogenesis process].

Bulnes S, García-Blanco Á, Bengoetxea H, Ortuzar N, Argandoña EG, Lafuente JV.

Rev Neurol. 2011 Jun 16;52(12):743-50. Review. Spanish.

4.

CD133(+) cells isolated from various sources and their role in future clinical perspectives.

Meregalli M, Farini A, Belicchi M, Torrente Y.

Expert Opin Biol Ther. 2010 Nov;10(11):1521-8. doi: 10.1517/14712598.2010.528386. Epub 2010 Oct 11. Review.

5.

The interface between glial progenitors and gliomas.

Canoll P, Goldman JE.

Acta Neuropathol. 2008 Nov;116(5):465-77. doi: 10.1007/s00401-008-0432-9. Epub 2008 Sep 11. Review.

6.

Glial progenitors as targets for transformation in glioma.

Ilkanizadeh S, Lau J, Huang M, Foster DJ, Wong R, Frantz A, Wang S, Weiss WA, Persson AI.

Adv Cancer Res. 2014;121:1-65. doi: 10.1016/B978-0-12-800249-0.00001-9. Review.

7.

Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology.

Katsetos CD, Legido A, Perentes E, Mörk SJ.

J Child Neurol. 2003 Dec;18(12):851-66; discussion 867. Review. Erratum in: J Child Neurol. 2004 Jul;19(7):531.

PMID:
14736079
8.

The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research.

Wan F, Zhang S, Xie R, Gao B, Campos B, Herold-Mende C, Lei T.

Brain Pathol. 2010 Sep;20(5):877-89. doi: 10.1111/j.1750-3639.2010.00379.x. Epub 2010 Feb 5. Review.

PMID:
20331619
9.

On the origin and growth of gliomas.

Schiffer D, Annovazzi L, Caldera V, Mellai M.

Anticancer Res. 2010 Jun;30(6):1977-98. Review.

PMID:
20651342
10.

Neuronal stem cells in the central nervous system and in human diseases.

Wu Q, Wang X.

Protein Cell. 2012 Apr;3(4):262-70. doi: 10.1007/s13238-012-2930-8. Epub 2012 Apr 20. Review.

11.

Neural stem cells and the origin of gliomas.

Sanai N, Alvarez-Buylla A, Berger MS.

N Engl J Med. 2005 Aug 25;353(8):811-22. Review. No abstract available.

PMID:
16120861
12.

Molecular markers in glioma.

Ludwig K, Kornblum HI.

J Neurooncol. 2017 Feb 23. doi: 10.1007/s11060-017-2379-y. [Epub ahead of print] Review.

PMID:
28233083
13.

Brain stem cells as the cell of origin in glioma.

Modrek AS, Bayin NS, Placantonakis DG.

World J Stem Cells. 2014 Jan 26;6(1):43-52. doi: 10.4252/wjsc.v6.i1.43. Review.

Supplemental Content

Support Center